Latest Advances

  • Condition: Korean Patients with Inflammatory Bowel Disease (IBD)
  • Journal: Medicine
  • Treatment Used: Physical Activity (PA)
  • Number of Patients: 158
  • Published —
This study examined the association between physical activity (PA) and quality of life (QOL) in Korean patients with inflammatory bowel disease (IBD).
  • Journal: Acta gastro-enterologica Belgica
  • Published —
Therapeutic outcome of diverticular associated colitis - a retrospective single centre experience.
  • Condition: Children with Moderate to Severe Ulcerative Colitis (UC)
  • Journal: Yonsei medical journal
  • Treatment Used: Infliximab (IFX) Therapy
  • Number of Patients: 44
  • Published —
This study evaluated infliximab (IFX) therapy in pediatric patients with moderate to severe ulcerative colitis (UC).
  • Journal: Archives of osteoporosis
  • Published —
Bone mineral density in spanish children at the diagnosis of inflammatory bowel disease.
  • Journal: Andes pediatrica : revista Chilena de pediatria
  • Published —
Study of personality and anxiety in children and adolescents with inflammatory bowel disease.
  • Journal: Neurology(R) neuroimmunology & neuroinflammation
  • Published —
Nodular Pachymeningitis Associated With Relapsing Polychondritis and Crohn Disease Responsive to Adalimumab and Prednisone.
  • Journal: International journal of environmental research and public health
  • Published —
Effectiveness of a Multicomponent Group Psychological Intervention Program in Patients with Inflammatory Bowel Disease: A Randomized Trial.
  • Journal: Vnitrni lekarstvi
  • Published —
Extraintestinal complications of inflammatory bowel diseases.
  • Condition: Chronic Antibiotic Refractory Pouchitis (CARP)
  • Journal: Journal of clinical gastroenterology
  • Treatment Used: Biological Therapy
  • Number of Patients: 311
  • Published —
This review of the literature evaluated the safety and effectiveness of different biological therapies in the treatment of patients with chronic antibiotic refractory pouchitis (CARP).
  • Condition: Inflammatory Bowel Disease (IBD)
  • Journal: Alimentary pharmacology & therapeutics
  • Treatment Used: Anti-Tumor Necrosis Factor (anti-TNF) Therapy Discontinuation
  • Number of Patients: 1000
  • Published —
This study assessed the risk of relapse after anti-tumor necrosis factor alpha (anti-TNF) discontinuation in patients with inflammatory bowel disease (IBD).
Showing 1-12 of 439